An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis

NCT02518620 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: ALX-0061

Sponsor

Ablynx, a Sanofi company